Panthers Coach Dave Canales Undergoes Basal Cell Carcinoma Removal
Panthers head coach Dave Canales had a small spot of basal cell carcinoma removed from his nose following a routine team skin cancer screening two months prior. Basal cell carcinoma is the most common form of skin cancer, typically caused by UV exposure from sunlight. Canales used the opportunity to encourage others to get screened early, noting his mother had the same condition in her 40s.
Panthers head coach Dave Canales revealed he recently underwent a procedure to remove basal cell carcinoma from his nose, the most common type of skin cancer. The condition was identified during a routine skin cancer screening conducted by the team two months earlier. The 45-year-old coach, who has spent 16 seasons in the NFL, emphasized the importance of early detection and preventive measures like sunscreen use. Canales noted his family history with the condition, as his mother experienced basal cell carcinoma in her 40s. He expressed gratitude for catching the cancer early and encouraged others not to overlook such health concerns. The coach appeared at the team's minicamp with a visible bandage on his nose.
What different sources said
- New York PostRight
Panthers coach Dave Canales has skin cancer removed from nose two months after screening
Related
Sydney Psychiatrist Retains Medical License After Sexual Assault Conviction
Gopi Ilawala, a Sydney psychiatrist convicted of sexually assaulting an intoxicated colleague in 2022, has been allowed to continue practicing medicine despite the state health regulator seeking to have his registration cancelled. The New South Wales Civil and Administrative Tribunal reprimanded him and imposed conditions rather than striking him off, citing his remorse, lack of prior convictions, and support from two senior psychiatrists. The decision raises questions about professional accountability and public protection in medical regulation.
Australia's TGA to crack down on illegal peptides; government allocates $100m for arthritis research
Australia's Therapeutic Goods Administration has announced a crackdown on illegal peptides due to a surge in imports and online advertising, designating them a priority focus area. The federal government has simultaneously committed $100 million to medical research into arthritis prevention, diagnosis, and treatment. These developments reflect growing regulatory concerns about unregulated drugs and increased investment in chronic disease research.
GLP-1 Drugs Like Ozempic May Help ADHD Symptoms, According to Patient Reports and Clinical Observations
Social media users and some patients are reporting that GLP-1 receptor agonist drugs like Ozempic appear to improve ADHD symptoms, including increased focus, reduced procrastination, and better impulse control. GLP-1s were originally developed to treat Type 2 diabetes but are being studied for various other conditions. While anecdotal reports are growing, no formal clinical trials are currently testing these drugs specifically for ADHD, and the mechanism behind any potential benefit remains unclear.